These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 33895981)

  • 21. Microvascular and macrovascular complications in type 2 diabetes Ghanaian residents in Ghana and Europe: The RODAM study.
    Hayfron-Benjamin C; van den Born BJ; Maitland-van der Zee AH; Amoah AGB; Meeks KAC; Klipstein-Grobusch K; Bahendeka S; Spranger J; Danquah I; Mockenhaupt F; Beune E; Smeeth L; Agyemang C
    J Diabetes Complications; 2019 Aug; 33(8):572-578. PubMed ID: 31167710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empagliflozin and Cardio-renal Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease - Implications for Clinical Practice.
    Fitchett DH
    Eur Endocrinol; 2018 Sep; 14(2):40-49. PubMed ID: 30349593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Legacy Effect of Intensive Blood Glucose Control on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Very High Risk or Secondary Prevention of Cardiovascular Disease: A Meta-analysis of Randomized Controlled Trials.
    Zhang X; Liu Y; Zhang F; Li J; Tong N
    Clin Ther; 2018 May; 40(5):776-788.e3. PubMed ID: 29656857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
    Dormandy JA; Charbonnel B; Eckland DJ; Erdmann E; Massi-Benedetti M; Moules IK; Skene AM; Tan MH; Lefèbvre PJ; Murray GD; Standl E; Wilcox RG; Wilhelmsen L; Betteridge J; Birkeland K; Golay A; Heine RJ; Korányi L; Laakso M; Mokán M; Norkus A; Pirags V; Podar T; Scheen A; Scherbaum W; Schernthaner G; Schmitz O; Skrha J; Smith U; Taton J;
    Lancet; 2005 Oct; 366(9493):1279-89. PubMed ID: 16214598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes.
    Handelsman Y
    Adv Ther; 2019 Oct; 36(10):2567-2586. PubMed ID: 31444707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis.
    Sheng B; Truong K; Spitler H; Zhang L; Tong X; Chen L
    Obes Surg; 2017 Oct; 27(10):2724-2732. PubMed ID: 28801703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral Semaglutide Reduces HbA
    Pratley RE; Crowley MJ; Gislum M; Hertz CL; Jensen TB; Khunti K; Mosenzon O; Buse JB
    Diabetes Ther; 2021 Apr; 12(4):1099-1116. PubMed ID: 33660198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
    van Steen SC; Woodward M; Chalmers J; Li Q; Marre M; Cooper ME; Hamet P; Mancia G; Colagiuri S; Williams B; Grobbee DE; DeVries JH;
    Diabetologia; 2018 Apr; 61(4):780-789. PubMed ID: 29308539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Socioeconomic status and time in glucose target range in people with type 2 diabetes: a baseline analysis of the GP-OSMOTIC study.
    Tan ML; Manski-Nankervis JA; Thuraisingam S; Jenkins A; O'Neal D; Furler J
    BMC Endocr Disord; 2018 Jul; 18(1):47. PubMed ID: 30031385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Historical HbA
    Lind M; Imberg H; Coleman RL; Nerman O; Holman RR
    Diabetes Care; 2021 Jul; 44(10):2231-7. PubMed ID: 34244332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the Menstrual Cycle on Neurological Disorders.
    Roeder HJ; Leira EC
    Curr Neurol Neurosci Rep; 2021 May; 21(7):34. PubMed ID: 33970361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of curcumin on proinflammatory cytokines: A meta-analysis of randomized controlled trials.
    Gorabi AM; Razi B; Aslani S; Abbasifard M; Imani D; Sathyapalan T; Sahebkar A
    Cytokine; 2021 Jul; 143():155541. PubMed ID: 33934954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescription medications for sleep disturbances among midlife women during 2 years of follow-up: a SWAN retrospective cohort study.
    Solomon DH; Ruppert K; Habel LA; Finkelstein JS; Lian P; Joffe H; Kravitz HM
    BMJ Open; 2021 May; 11(5):e045074. PubMed ID: 33975865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease.
    Haberman RH; Herati R; Simon D; Samanovic M; Blank RB; Tuen M; Koralov SB; Atreya R; Tascilar K; Allen JR; Castillo R; Cornelius AR; Rackoff P; Solomon G; Adhikari S; Azar N; Rosenthal P; Izmirly P; Samuels J; Golden B; Reddy SM; Neurath MF; Abramson SB; Schett G; Mulligan MJ; Scher JU
    Ann Rheum Dis; 2021 Oct; 80(10):1339-1344. PubMed ID: 34035003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Glycemic Control on Coronary Inflammation Evaluated by Computed Tomography Pericoronary Fat Attenuation Index in Patients with Acute Coronary Syndrome.
    Jiang J; Yin Y; Li Y; Xu B; Zou Z; Ding S; Pu J
    Rev Cardiovasc Med; 2023 Jul; 24(7):203. PubMed ID: 39077018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors Associated with Increased Intraocular Pressure in Type 2 Diabetes Patients.
    Braha A; Simion A; Timar R; Timar B
    J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unraveling shared risk factors for diabetic foot ulcer: a comprehensive Mendelian randomization analysis.
    Yin K; Qiao T; Zhang Y; Liu J; Wang Y; Qi F; Deng J; Zhao C; Xu Y; Cao Y
    BMJ Open Diabetes Res Care; 2023 Nov; 11(6):. PubMed ID: 37989345
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.